About MUbio

Mission:

To develop high quality reagents and antigens for better research, diagnostics and treatment of cancer

MUbio Products B.V. (MUbio) is a privately owned Dutch biotech company, founded in 2000 by Dr. R. Vleugels and Prof. Dr. F. Ramaekers. The company originated as a spin out from the Department of Molecular Cell Biology of the Maastricht University.

MUbio produces high quality reagents and bioassays for cell biology and biomedical research. MUbio's product portfolio includes an increasing number of well-characterized antibodies for oncology research, produced in an ISO certified laboratory.

MUbio’s partnered and proprietary R&D projects focus on:

• identification and validation of viral (CMV) and tumor (lung cancer) antigens
• development of CMV and lung cancer diagnostic kits
• development of CMV and lung cancer vaccines